Our Team
We are innovating scientific discoveries into therapies that matter to patients. With our headquarters in Las Vegas, business development in San Francisco and research and development in Tokyo, we are a global team focused on developing a less toxic chemotherapy.
Our experience, combined, brought nanomedicines from invention to phase 3 clinical trials in oncology
John D. Martin, PhD
Chief Executive Officer
Atsushi Osada, MBA
Vice President, Clinical Development Japan
Jessica Sorrentino, PhD
Chief Scientific Officer
Medina K. Poole, PMP
Chief Operating Officer
Professor Horacio Cabral
Advisor
Drug Discovery
Philip Hsieh
Senior Associate
Business Development
Takehiko Ishii, PhD
Advisor
Polymer Chemistry
Shen (Sunny) Liang
Director
Business Development
Vinicio Melo, PhD
Advisor
Tumor Biology
Masaharu Miyajima, PhD
Advisor
CMC & Regulatory Affairs
Professor Yuki Mochida
Advisor
Platinum-based Polymeric Micelles
Professor Matthew Stuber
Advisor
Computational Science
Shinpei Tatebayashi, PhD
Scientist
Nonclinical
Megan Walsh, PhD
Scientist
Computational Science
Sei Yoshida, MS
Advisor
Chemistry
Partners
Our Global Offices
TOKYO
SAN FRANCISCO
